Bundesministerium für Bildung und Forschung

Launch of ventilation hygiene project

The BMBF joint research project “Disinfection of exhaust air from respiratory equipment with cold plasma (respiratory hygiene)” was approved on 8.8.2022 which begins from 1.9.2022 for three years and is funded by the BMBF with the funding code 13GW0599A. The project is being carried out together with partners from the Fraunhofer Gesellschaft (IKTS, Dresden and IZI, Leipzig) and the companies QSIL Ceramics GmbH and Inmatec Technologies GmbH under the coordination of terraplasma GmbH – and has a total volume of approx. 3 million €.

Project description

Project description

“Hospital Associated Infections (HAI)” are not only a corona phenomenon in Germany with up to 600,000 infections and 20,000 deaths annually. The increase in multi-resistant pathogens is particularly critical. According to a study by the AMR Industry Alliance, deaths due to drug resistance could rise to about 10 million worldwide in 2050.

HAIs are particularly prevalent in intensive care units (ICUs) and 98% of HAIs in ICUs are associated with intubation. The spread of pathogens through ventilation and suction equipment is a critical point in the protective technology used to date. Germs are filtered but not killed. The daily change and disposal of filters is therefore a permanent danger for hospital staff and patients.

The solution approach of our project is the combination of proven filters with built-in plasma modules for the inactivation of bacteria and viruses directly in the respiratory exhaust air or in the suction area of the devices. The plasma treatment is based on highly efficient physical processes that prevent the formation of resistance.

The intended development of a stable and cost-effective ceramic plasma electrode, together with a robust and reliable disinfection technique, will make a significant contribution to safety in hospitals and other healthcare facilities.

Short Notice

Impressions from BayOConnect 2024 in Munich

“replacing chemicals. the sustainable way.” Under this motto, the innovation leader from Garching near Munich promotes the many different possible uses of cold plasma technology in the areas of biotech and life science. Cold plasma is perfect for replacing conventional disinfection solutions with chemicals, UV, heat or radiation, for example, and thus enables true sustainability. An excellently suitable platform is the BayOConnect 2024 event, in which terraplasma actively participated as speaker and exhibitor.

Read more »
Press release

Aerosol-assisted cold plasma technology from terraplasma for disinfecting surfaces reaches important milestone

Cold atmospheric plasma (cold plasma for short) is already proving its effectiveness in the treatment of chronic and acute wounds by reducing microorganisms without contact or chemicals. Viruses, fungi and bacteria, including multi-resistant pathogens (MRE), are efficiently and sustainably destroyed by cold plasma. It therefore made sense to extend this active principle to other areas of application, such as the disinfection of objects and surfaces. With a prototype called “tpTop”, a handy and mobile cold plasma decontamination device with aerosol support, it has now been possible to deactivate up to 99.9% of microorganisms within a few seconds of treatment. This opens up new application possibilities for the future, such as the fast and sustainable disinfection of surfaces of all kinds.

Read more »
Event notice

Cold plasma, biotech and life science: terraplasma shows sustainable innovations in Munich

“replacing chemicals. the sustainable way.” Under this motto, the innovation leader from Garching near Munich promotes the many different possible uses of cold plasma technology in the areas of biotech and life science. Cold plasma is perfect for replacing conventional disinfection solutions with chemicals, UV, heat or radiation, for example, and thus enables true sustainability. An excellently suitable platform is the BayOConnect event, in which terraplasma actively participates as an exhibitor.

Read more »

Subscribe to our newsletter

Do not miss any more news about Cold Plasma
and subscribe to our newsletter.